0001880441 false --12-31 2023 Q3 0001880441 2023-01-01 2023-09-30 0001880441 us-gaap:CapitalUnitsMember 2023-01-01 2023-09-30 0001880441 us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001880441 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001880441 us-gaap:CommonClassAMember 2023-11-13 0001880441 us-gaap:CommonClassBMember 2023-11-13 0001880441 2023-09-30 0001880441 2022-12-31 0001880441 us-gaap:CommonClassAMember 2023-09-30 0001880441 us-gaap:CommonClassAMember 2022-12-31 0001880441 us-gaap:CommonClassBMember 2023-09-30 0001880441 us-gaap:CommonClassBMember 2022-12-31 0001880441 2023-07-01 2023-09-30 0001880441 2022-07-01 2022-09-30 0001880441 2022-01-01 2022-09-30 0001880441 bfac:ClassARedeemableOrdinarySharesMember 2023-07-01 2023-09-30 0001880441 bfac:ClassARedeemableOrdinarySharesMember 2022-07-01 2022-09-30 0001880441 bfac:ClassARedeemableOrdinarySharesMember 2023-01-01 2023-09-30 0001880441 bfac:ClassARedeemableOrdinarySharesMember 2022-01-01 2022-09-30 0001880441 bfac:ClassBNonRedeemableOrdinaryShareMember 2023-07-01 2023-09-30 0001880441 bfac:ClassBNonRedeemableOrdinaryShareMember 2022-07-01 2022-09-30 0001880441 bfac:ClassBNonRedeemableOrdinaryShareMember 2023-01-01 2023-09-30 0001880441 bfac:ClassBNonRedeemableOrdinaryShareMember 2022-01-01 2022-09-30 0001880441 bfac:ClassBOrdinarySharesMember 2022-12-31 0001880441 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001880441 us-gaap:RetainedEarningsMember 2022-12-31 0001880441 bfac:ClassBOrdinarySharesMember 2023-03-31 0001880441 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001880441 us-gaap:RetainedEarningsMember 2023-03-31 0001880441 2023-03-31 0001880441 bfac:ClassBOrdinarySharesMember 2023-06-30 0001880441 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001880441 us-gaap:RetainedEarningsMember 2023-06-30 0001880441 2023-06-30 0001880441 bfac:ClassBOrdinarySharesMember 2021-12-31 0001880441 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001880441 us-gaap:RetainedEarningsMember 2021-12-31 0001880441 2021-12-31 0001880441 bfac:ClassBOrdinarySharesMember 2022-03-31 0001880441 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001880441 us-gaap:RetainedEarningsMember 2022-03-31 0001880441 2022-03-31 0001880441 bfac:ClassBOrdinarySharesMember 2022-06-30 0001880441 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001880441 us-gaap:RetainedEarningsMember 2022-06-30 0001880441 2022-06-30 0001880441 bfac:ClassBOrdinarySharesMember 2023-01-01 2023-03-31 0001880441 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001880441 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001880441 2023-01-01 2023-03-31 0001880441 bfac:ClassBOrdinarySharesMember 2023-04-01 2023-06-30 0001880441 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001880441 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001880441 2023-04-01 2023-06-30 0001880441 bfac:ClassBOrdinarySharesMember 2023-07-01 2023-09-30 0001880441 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001880441 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001880441 bfac:ClassBOrdinarySharesMember 2022-01-01 2022-03-31 0001880441 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001880441 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001880441 2022-01-01 2022-03-31 0001880441 bfac:ClassBOrdinarySharesMember 2022-04-01 2022-06-30 0001880441 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001880441 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001880441 2022-04-01 2022-06-30 0001880441 bfac:ClassBOrdinarySharesMember 2022-07-01 2022-09-30 0001880441 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001880441 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001880441 bfac:ClassBOrdinarySharesMember 2023-09-30 0001880441 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001880441 us-gaap:RetainedEarningsMember 2023-09-30 0001880441 bfac:ClassBOrdinarySharesMember 2022-09-30 0001880441 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001880441 us-gaap:RetainedEarningsMember 2022-09-30 0001880441 2022-09-30 0001880441 us-gaap:IPOMember 2021-12-10 2021-12-17 0001880441 us-gaap:CommonClassAMember 2021-12-17 0001880441 bfac:PublicWarrantsMember 2021-12-10 2021-12-17 0001880441 bfac:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2021-12-10 2021-12-17 0001880441 us-gaap:CommonClassBMember us-gaap:PrivatePlacementMember 2021-12-10 2021-12-17 0001880441 us-gaap:CommonClassBMember us-gaap:PrivatePlacementMember 2021-12-17 0001880441 us-gaap:PrivatePlacementMember 2021-12-10 2021-12-17 0001880441 bfac:PrivatePlacementWarrantsMember bfac:SponsorMember 2021-12-10 2021-12-17 0001880441 bfac:PrivatePlacementWarrantsMember bfac:PalaInvestmentsLimitedOrPalaMember us-gaap:PrivatePlacementMember 2021-12-10 2021-12-17 0001880441 bfac:PalaInvestmentsLimitedOrPalaMember us-gaap:CommonClassBMember us-gaap:PrivatePlacementMember 2021-12-10 2021-12-17 0001880441 bfac:PrivatePlacementWarrantsMember bfac:CantorFitzgeraldandCoOrCantorMember us-gaap:PrivatePlacementMember 2021-12-10 2021-12-17 0001880441 bfac:PrivatePlacementWarrantsMember bfac:RothCapitalPartnersLlcOrRothMember us-gaap:PrivatePlacementMember 2021-12-10 2021-12-17 0001880441 bfac:RothCapitalPartnersLlcOrRothMember us-gaap:CommonClassBMember us-gaap:PrivatePlacementMember 2021-12-10 2021-12-17 0001880441 2021-12-17 0001880441 bfac:OtherInvesteeMember 2023-09-30 0001880441 2021-12-10 2021-12-17 0001880441 us-gaap:PrivatePlacementMember 2021-12-17 0001880441 2023-05-18 0001880441 bfac:PublicShareMember us-gaap:IPOMember 2023-01-01 2023-09-30 0001880441 bfac:PublicShareMember us-gaap:IPOMember 2023-09-30 0001880441 us-gaap:SubsequentEventMember 2023-11-10 2023-11-17 0001880441 2023-06-01 2023-06-12 0001880441 2023-06-12 0001880441 us-gaap:CommonClassAMember 2023-06-12 0001880441 us-gaap:CommonClassBMember 2023-06-12 0001880441 2023-06-01 2023-06-14 0001880441 2023-06-14 0001880441 bfac:PalaMember 2023-08-15 0001880441 bfac:PalaMember 2023-09-15 0001880441 bfac:PalaMember us-gaap:SubsequentEventMember 2023-10-12 0001880441 bfac:WorkingCapitalLoansMember bfac:SponsorMember 2023-09-30 0001880441 bfac:WorkingCapitalLoansMember bfac:SponsorMember 2022-12-31 0001880441 us-gaap:IPOMember 2023-01-01 2023-09-30 0001880441 bfac:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2022-01-01 2022-12-31 0001880441 bfac:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2022-12-31 0001880441 bfac:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2023-01-01 2023-03-31 0001880441 bfac:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2023-03-31 0001880441 bfac:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2023-04-01 2023-06-30 0001880441 bfac:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2023-06-30 0001880441 bfac:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2023-07-01 2023-09-30 0001880441 bfac:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2023-09-30 0001880441 bfac:ClassAOrdinarySharesMember 2023-07-01 2023-09-30 0001880441 bfac:ClassBOrdinarySharesMember 2023-07-01 2023-09-30 0001880441 bfac:ClassAOrdinarySharesMember 2022-07-01 2022-09-30 0001880441 bfac:ClassBOrdinarySharesMember 2022-07-01 2022-09-30 0001880441 bfac:ClassAOrdinarySharesMember 2023-01-01 2023-09-30 0001880441 bfac:ClassBOrdinarySharesMember 2023-01-01 2023-09-30 0001880441 bfac:ClassAOrdinarySharesMember 2022-01-01 2022-09-30 0001880441 bfac:ClassBOrdinarySharesMember 2022-01-01 2022-09-30 0001880441 us-gaap:IPOMember 2021-12-17 0001880441 bfac:PublicWarrantsMember 2023-09-30 0001880441 bfac:ShareIssuePriceOneMember us-gaap:CommonClassAMember 2023-09-30 0001880441 bfac:PublicWarrantsMember 2023-01-01 2023-09-30 0001880441 bfac:ShareIssuePriceOneMember 2023-09-30 0001880441 bfac:ShareIssuePriceTwoMember 2023-09-30 0001880441 bfac:PublicWarrantsMember 2022-01-01 2022-09-30 0001880441 bfac:PrivatePlacementWarrantsMember 2023-01-01 2023-09-30 0001880441 bfac:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2023-01-01 2023-09-30 0001880441 us-gaap:CommonClassBMember us-gaap:PrivatePlacementMember 2023-01-01 2023-09-30 0001880441 us-gaap:CommonClassBMember us-gaap:PrivatePlacementMember 2022-12-31 0001880441 us-gaap:PrivatePlacementMember 2023-01-01 2023-09-30 0001880441 bfac:PrivatePlacementWarrantsMember bfac:SponsorMember us-gaap:PrivatePlacementMember 2023-01-01 2023-09-30 0001880441 bfac:PrivatePlacementWarrantsMember bfac:PalaInvestmentsLimitedOrPalaMember us-gaap:PrivatePlacementMember 2023-01-01 2023-09-30 0001880441 bfac:PalaInvestmentsLimitedOrPalaMember us-gaap:CommonClassBMember us-gaap:PrivatePlacementMember 2023-01-01 2023-09-30 0001880441 bfac:PrivatePlacementWarrantsMember bfac:CantorFitzgeraldandCoOrCantorMember us-gaap:PrivatePlacementMember 2023-01-01 2023-09-30 0001880441 bfac:PrivatePlacementWarrantsMember bfac:RothCapitalPartnersLlcOrRothMember us-gaap:PrivatePlacementMember 2023-01-01 2023-09-30 0001880441 bfac:RothCapitalPartnersLlcOrRothMember us-gaap:CommonClassBMember us-gaap:PrivatePlacementMember 2023-01-01 2023-09-30 0001880441 bfac:SponsorMember us-gaap:CommonClassBMember 2021-08-01 2021-08-04 0001880441 bfac:SponsorMember us-gaap:CommonClassBMember 2021-08-04 0001880441 bfac:SponsorMember us-gaap:CommonClassBMember 2021-11-20 2021-11-21 0001880441 bfac:RothCapitalPartnersLlcOrRothMember us-gaap:CommonClassBMember us-gaap:PrivatePlacementMember 2021-11-20 2021-11-21 0001880441 bfac:PrivatePlacementWarrantsMember bfac:RothCapitalPartnersLlcOrRothMember us-gaap:PrivatePlacementMember 2021-10-20 2021-11-21 0001880441 bfac:PalaInvestmentsLimitedOrPalaMember us-gaap:CommonClassBMember us-gaap:PrivatePlacementMember 2021-11-20 2021-11-21 0001880441 bfac:PrivatePlacementWarrantsMember bfac:PalaInvestmentsLimitedOrPalaMember us-gaap:PrivatePlacementMember 2021-11-20 2021-11-21 0001880441 bfac:SponsorMember us-gaap:CommonClassBMember 2021-12-10 2021-12-14 0001880441 us-gaap:CommonClassBMember 2021-12-14 0001880441 bfac:SponsorMember us-gaap:CommonClassBMember 2021-12-14 0001880441 bfac:PalaInvestmentsLimitedOrPalaMember us-gaap:CommonClassBMember 2021-12-14 0001880441 bfac:RothCapitalPartnersLlcOrRothMember us-gaap:CommonClassBMember 2021-12-14 0001880441 bfac:PalaInvestmentsLimitedOrPalaMember us-gaap:CommonClassBMember 2021-12-10 2021-12-16 0001880441 us-gaap:CommonClassBMember 2021-12-16 0001880441 bfac:SponsorMember us-gaap:CommonClassBMember 2021-12-16 0001880441 bfac:PalaInvestmentsLimitedOrPalaMember us-gaap:CommonClassBMember 2021-12-16 0001880441 bfac:RothCapitalPartnersLlcOrRothMember us-gaap:CommonClassBMember 2021-12-16 0001880441 us-gaap:CommonClassBMember 2021-12-17 0001880441 bfac:ClassAOrdinarySharesSubjectToPossibleRedemptionMember us-gaap:SubsequentEventMember 2023-10-15 2023-10-23 0001880441 bfac:ClassAOrdinarySharesSubjectToPossibleRedemptionMember us-gaap:SubsequentEventMember 2023-10-15 2023-10-30 0001880441 bfac:ClassAOrdinarySharesSubjectToPossibleRedemptionMember us-gaap:SubsequentEventMember 2023-11-01 2023-11-06 0001880441 bfac:SponsorMember us-gaap:SubsequentEventMember 2023-10-23 0001880441 bfac:SponsorMember us-gaap:SubsequentEventMember 2023-10-30 0001880441 bfac:SponsorMember us-gaap:SubsequentEventMember 2023-11-06 0001880441 bfac:PromissoryNoteMember bfac:SponsorMember 2021-08-03 0001880441 bfac:UnsecuredPromissoryNoteMember bfac:PalaInvestmentsLimitedOrPalaMember 2023-04-05 0001880441 srt:MinimumMember bfac:UnsecuredPromissoryNoteMember bfac:PalaInvestmentsLimitedOrPalaMember 2023-04-05 0001880441 bfac:UnsecuredPromissoryNoteMember bfac:PalaInvestmentsLimitedOrPalaMember 2023-04-01 2023-04-05 0001880441 bfac:PalaWorkingCapitalNoteMember 2023-07-01 2023-09-30 0001880441 bfac:PalaWorkingCapitalNoteMember 2023-01-01 2023-09-30 0001880441 srt:MaximumMember bfac:PalaTrustExtensionLoansMember 2023-08-08 0001880441 srt:MaximumMember bfac:PalaTrustExtensionLoansMember 2023-08-01 2023-08-08 0001880441 bfac:ExtensionLoanMember bfac:SponsorMember 2023-06-14 0001880441 bfac:ExtensionLoanMember bfac:SponsorMember 2023-09-30 0001880441 bfac:ExtensionLoanAmendedAndRestatedMember bfac:SponsorMember 2023-07-31 0001880441 bfac:SponsorWorkingCapitalLoansMember 2023-07-01 2023-07-31 0001880441 bfac:PalaTrustExtensionLoansMember 2023-07-01 2023-07-31 0001880441 srt:MaximumMember bfac:SponsorWorkingCapitalLoansMember 2023-08-08 0001880441 bfac:ExtensionLoanAmendedAndRestatedMember bfac:SponsorMember us-gaap:SubsequentEventMember 2023-10-12 0001880441 bfac:WorkingCapitalLoansMember 2023-09-30 0001880441 bfac:WorkingCapitalLoansMember 2022-12-31 0001880441 bfac:OfficeSpaceSecretarialAndAdministrativeServicesMember bfac:SponsorMember 2023-01-01 2023-09-30 0001880441 bfac:AdministrativeSupportAgreementMember bfac:SponsorMember 2023-09-30 0001880441 bfac:AdministrativeSupportAgreementMember bfac:SponsorMember 2022-12-31 0001880441 bfac:WorkingCapitalLoanMember us-gaap:RelatedPartyMember us-gaap:OverAllotmentOptionMember 2022-12-31 0001880441 us-gaap:WarrantMember 2022-12-31 0001880441 srt:MinimumMember us-gaap:CommonClassAMember bfac:FounderSharesMember 2023-09-25 2023-09-30 0001880441 bfac:PrivatePlacementWarrantsMember 2022-12-31 0001880441 bfac:PrivatePlacementWarrantsMember bfac:WorkingCapitalLoanMember us-gaap:CommonClassAMember 2022-12-31 0001880441 srt:MaximumMember us-gaap:CommonClassAMember bfac:FounderSharesMember 2023-09-25 2023-09-30 0001880441 bfac:PrivatePlacementWarrantsMember bfac:WorkingCapitalLoanMember 2022-12-31 0001880441 us-gaap:OverAllotmentOptionMember 2021-12-10 2021-12-17 0001880441 us-gaap:IPOMember 2023-09-30 0001880441 bfac:PublicWarrantsMember us-gaap:IPOMember 2023-09-30 0001880441 bfac:PrivatePlacementWarrantsMember us-gaap:IPOMember 2023-09-30 0001880441 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember bfac:PublicWarrantsMember 2023-09-30 0001880441 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember bfac:PublicWarrantsMember 2023-09-30 0001880441 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember bfac:PublicWarrantsMember 2023-09-30 0001880441 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember bfac:PrivateWarrantsMember 2023-09-30 0001880441 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember bfac:PrivateWarrantsMember 2023-09-30 0001880441 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember bfac:PrivateWarrantsMember 2023-09-30 0001880441 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001880441 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001880441 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-09-30 0001880441 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001880441 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001880441 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001880441 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001880441 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001880441 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001880441 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember bfac:PublicWarrantsMember 2022-12-31 0001880441 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember bfac:PublicWarrantsMember 2022-12-31 0001880441 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember bfac:PublicWarrantsMember 2022-12-31 0001880441 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember bfac:PrivateWarrantsMember 2022-12-31 0001880441 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember bfac:PrivateWarrantsMember 2022-12-31 0001880441 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember bfac:PrivateWarrantsMember 2022-12-31 0001880441 2022-01-01 2022-12-31 0001880441 bfac:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001880441 bfac:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001880441 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001880441 bfac:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001880441 bfac:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001880441 us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001880441 bfac:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001880441 bfac:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001880441 us-gaap:FairValueInputsLevel3Member 2023-03-31 0001880441 bfac:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2023-04-01 2023-06-30 0001880441 bfac:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member 2023-04-01 2023-06-30 0001880441 us-gaap:FairValueInputsLevel3Member 2023-04-01 2023-06-30 0001880441 bfac:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001880441 bfac:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001880441 us-gaap:FairValueInputsLevel3Member 2023-06-30 0001880441 bfac:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2023-07-01 2023-09-30 0001880441 bfac:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member 2023-07-01 2023-09-30 0001880441 us-gaap:FairValueInputsLevel3Member 2023-07-01 2023-09-30 0001880441 bfac:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0001880441 bfac:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0001880441 us-gaap:FairValueInputsLevel3Member 2023-09-30 0001880441 us-gaap:CommonClassBMember 2023-01-01 2023-09-30 0001880441 us-gaap:SubsequentEventMember 2023-10-24 0001880441 us-gaap:SubsequentEventMember 2023-10-23 0001880441 us-gaap:SubsequentEventMember 2023-10-30 0001880441 us-gaap:SubsequentEventMember 2023-11-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure bfac:Integer

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2023

 

OR

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________ to ________

 

BATTERY FUTURE ACQUISITION CORP.

(Exact name of registrant as specified in its charter)

 

Cayman Islands   001-41158   98-1618517

(State or other jurisdiction
of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

 

777 Brickell Ave #500-97545

Miami, Florida 33131

(Address of principal executive offices, including zip code)

 

Registrant’s telephone number, including area code: +61 460-545-788

 

 

(Former name or former address, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading Symbol(s)

  

Name of each exchange on which registered

Units, each consisting of one Class A ordinary share, par value $0.0001, and one-half of one redeemable warrant

   BFAC.U   The New York Stock Exchange
Class A ordinary shares, par value $0.0001   BFAC   The New York Stock Exchange
Redeemable warrants, each warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share   BFAC.WS   The New York Stock Exchange

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒   No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒   No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2under the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
    Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule12b-2 under the Exchange Act). Yes ☒   No ☐

 

As of November 13, 2023, 11,436,925 Class A ordinary shares, par value $0.0001 per share, and 8,625,000 Class B ordinary shares, par value $0.0001 per share, were issued and outstanding, respectively.

 

 

 

 

 

 

BATTERY FUTURE ACQUISITION CORP.

Form 10-Q

For the Quarter Ended September 30, 2023

Table of Contents

 

        Page
PART I. FINANCIAL INFORMATION    
Item 1.   Financial Statements   1
    Condensed Balance Sheets as of September 30, 2023 (Unaudited) and December 31, 2022   1
    Unaudited Condensed Statements of Operations for the three and nine months ended September 30, 2023 and 2022   2
    Unaudited Condensed Statements of Changes in Shareholders’ Deficit for the three and nine months ended September 30, 2023 and 2022   3
    Unaudited Condensed Statements of Cash Flows for the nine months ended September 30, 2023 and 2022   4
    Notes to Unaudited Condensed Financial Statements   5
Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations   23
Item 3.   Quantitative and Qualitative Disclosures About Market Risk   30
Item 4.   Controls and Procedures   30
         
PART II. OTHER INFORMATION    
Item 1.   Legal Proceedings   31
Item 1A.   Risk Factors   31
Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds   31
Item 3.   Defaults Upon Senior Securities   32
Item 4.   Mine Safety Disclosures   32
Item 5.   Other Information   32
Item 6.   Exhibits   33
         
SIGNATURE   34

 

i

 

 

PART I-FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

BATTERY FUTURE ACQUISITION CORP.

CONDENSED BALANCE SHEETS

 

                 
    September 30,
2023		     December 31,
2022		  
    (Unaudited)        
Assets:                
Cash   $ 123,724     $ 299,149  
Prepaid expenses     92,083       389,583  
Total current assets     215,807       688,732  
Cash and investments held in Trust Account     123,589,515       356,976,495  
Total Assets   $ 123,805,322     $ 357,665,227  
                 
Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit                
Accounts payable and accrued expenses   $ 2,054,546     $ 614,839  
Due to related party     1,797,343       11,820  
Total current liabilities     3,851,889       626,659  
Warrant liabilities     3,806,268       2,219,165  
Total Liabilities     7,658,157       2,845,824  
Commitments and Contingencies                
Class A ordinary shares subject to possible redemption, $0.0001 par value, 11,436,925 and 34,500,000 shares at an approximate redemption value of $10.81 per share as of September 30, 2023 and $10.35 per share as of December 31, 2022     123,588,627       356,975,607  
Shareholders’ Deficit:                
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of September 30, 2023 and December 31, 2022     -       -  
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; none outstanding (excluding 11,436,925 and 34,500,000 shares subject to possible redemption issued) as of September 30, 2023 and December 31, 2022, respectively     -       -  
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 8,625,000 shares issued and outstanding as of September 30, 2023 and December 31, 2022     863       863  
Additional paid-in capital     -       -  
Accumulated deficit     (7,442,325 )     (2,157,067 )
Total Shareholders’ Deficit     (7,441,462 )     (2,156,204 )
Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit   $ 123,805,322     $ 357,665,227  

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

1

 

 

BATTERY FUTURE ACQUISITION CORP.

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS

 

                                 
    For the
Three Months Ended
September 30,		     For the
Nine Months Ended
September 30,		  
    2023     2022     2023     2022  
General and administrative expenses   $ 728,366     $ 235,151     $ 2,670,974     $ 1,379,322  
Loss from operations     (728,366 )     (235,151 )     (2,670,974 )     (1,379,322 )
Other income (expense):                                
Interest earned on investment held in Trust Account     2,221,087       1,588,335       8,881,728       2,098,809  
Interest on promissory note - related party     (15,044 )     -       (27,181 )     -  
Change in fair value of warrant liabilities     (683,593 )     2,382,595       (1,587,103 )     16,142,727  
Total other income (expense), net     1,522,450       3,970,930       7,267,444       18,241,536  
Net income   $ 794,084     $ 3,735,779     $ 4,596,470     $ 16,862,214  
                                 
Weighted average redeemable Class A ordinary shares outstanding     11,436,925       34,500,000       25,122,706       34,500,000  
Basic and diluted net income per share, Class A redeemable ordinary shares   $ 0.04     $ 0.09     $ 0.14     $ 0.39  
Weighted average non-redeemable Class B ordinary shares outstanding     8,625,000       8,625,000       8,625,000       8,625,000  
Basic and diluted net income per share, Class B non-redeemable ordinary shares   $ 0.04     $ 0.09     $ 0.14     $ 0.39  

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

2

 

 

BATTERY FUTURE ACQUISITION CORP.

UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023

 

                                         
    Class B
Ordinary Shares		     Additional
Paid-in		     Accumulated     Total
Shareholders’		  
    Shares     Amount     Capital     Deficit     Deficit  
Balance — December 31, 2022     8,625,000     $ 863     $ -     $ (2,157,067 )   $ (2,156,204 )
Net income     -       -       -       2,176,769       2,176,769  
Accretion for shares subject to possible redemption     -       -       -       (3,787,699 )     (3,787,699 )
Balance — March 31, 2023 (unaudited)     8,625,000       863       -       (3,767,997 )     (3,767,134 )
Net income     -       -       -       1,625,617       1,625,617  
Accretion for shares subject to possible redemption     -       -       -       (3,372,942 )     (3,372,942 )
Balance — June 30, 2023 (unaudited)     8,625,000       863       -       (5,515,322 )     (5,514,459 )
Net income     -       -       -       794,084       794,084  
Accretion for shares subject to possible redemption     -       -       -       (2,721,087 )     (2,721,087 )
Balance — September 30, 2023 (unaudited)     8,625,000     $ 863     $ -     $ (7,442,325 )   $ (7,441,462 )

 

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022

 

    Class B
Ordinary Shares		     Additional
Paid-in		     Accumulated     Total
Shareholders’		  
    Shares     Amount     Capital     Deficit     Deficit  
Balance — December 31, 2021     8,625,000     $ 863     $ -     $ (18,334,458 )   $ (18,333,595 )
Net income     -       -       -       10,528,741       10,528,741  
Balance — March 31, 2022 (unaudited)     8,625,000       863       -       (7,805,717 )     (7,804,854 )
Net income     -       -       -       2,597,694       2,597,694  
Accretion for shares subject to possible redemption     -       -       -       (511,362 )     (511,362 )
Balance — June 30, 2022 (unaudited)     8,625,000       863       -       (5,719,385 )     (5,718,522 )
Net income     -       -       -       3,735,779       3,735,779  
Accretion for shares subject to possible redemption     -       -       -       (1,587,447 )     (1,587,447 )
Balance — September 30, 2022 (unaudited)     8,625,000     $ 863     $ -     $ (3,571,053 )   $ (3,570,190 )

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

3

 

 

BATTERY FUTURE ACQUISITION CORP.

UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS

 

                 
    For the
Nine Months Ended
September 30,		  
    2023     2022  
Cash Flows from Operating Activities:                
Net income   $ 4,596,470     $ 16,862,214  
Adjustments to reconcile net income to net cash used in operating activities:                
Interest earned on investments held in Trust Account     (8,881,728 )     (2,098,809 )
Interest on working capital loan – related party     27,181       -  
Change in fair value of warrant liabilities     1,587,103       (16,142,727 )
Changes in operating assets and liabilities:                
Prepaid expenses     297,500       (14,365 )
Prepaid expenses –non-current portion     -       343,688  
Accounts payable     1,439,707       434,551  
Due to related party     -       45,000  
Net cash used in operating activities     (933,767 )     (570,448 )
Cash Flows from Investing Activities:                
Investment of cash in Trust Account     (1,000,000 )     -  
Cash withdrawn from Trust Account in connection with redemption     243,268,708       -  
Net cash provided by investing activities     242,268,708       -  
Cash Flows from Financing Activities:                
Proceeds from promissory note     1,758,342       -  
Redemption of ordinary shares     (243,268,708 )     -  
Net cash used in financing activities     (241,510,366 )     -  
Net Change in Cash     (175,425 )     (570,448 )
Cash – Beginning of period     299,149       925,758  
Cash – End of period   $ 123,724     $ 355,310  

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

4

 

 

BATTERY FUTURE ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2023

 

NOTE 1 – ORGANIZATION, BUSINESS OPERATION AND LIQUIDITY

 

Battery Future Acquisition Corp. (the “Company”) was incorporated as a Cayman Islands exempted company on July 29, 2021. The Company was incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar Business Combination with one or more businesses (“Business Combination”).

 

As of September 30, 2023, the Company had not commenced any operations. All activity for the period from July 29, 2021 (inception) through September 30, 2023, relates to the Company’s formation and the initial public offering (“Public Offering” or “IPO”) described below, and since the Public Offering, the Company’s search for a prospective Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Public Offering. The Company has selected December 31 as its fiscal year end.

 

The Company’s sponsor is Battery Future Sponsor LLC, a Delaware limited liability company (the “Sponsor”).

 

The registration statement for the Company’s Public Offering was declared effective on December 14, 2021 (the “Effective Date”). On December 17, 2021, the Company consummated the IPO of 34,500,000 units (including the underwriters’ full exercise of their over-allotment option) at $10.00 per unit (the “Units” and, with respect to the Class A ordinary shares included in the Units, the “public shares”), which is discussed in Note 3. Each Unit consists of one Class A ordinary share and one-half of one redeemable warrant (the “Public Warrants”). Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share.

 

Simultaneously with the consummation of the IPO, the Company consummated the private placement of 16,300,000 warrants (the “Private Placement Warrants”) and 3,051,111 Class B ordinary shares, par value $0.0001 per share, of the Company (the “Founder Shares”) to the Sponsor, Pala Investments Limited (“Pala”), Cantor Fitzgerald & Co. (“Cantor”) and Roth Capital Partners, LLC (“Roth”), generating gross proceeds to the Company of $16,300,000 (the “Private Placement”). In the Private Placement, the Sponsor purchased an aggregate of 9,445,000 Private Placement Warrants, Pala purchased an aggregate of 3,095,000 Private Placement Warrants and 2,751,111 Founder Shares, Cantor purchased an aggregate of 2,760,000 Private Placement Warrants and Roth purchased an aggregate of 1,000,000 Private Placement Warrants and 300,000 Founder Shares.

 

Transaction costs related to the IPO amounted to $7,607,233, consisting of $6,900,000 of underwriting commissions, and $707,233 of other offering costs. In addition, $979,690 of cash was held outside of the Trust Account (as defined below) and was available for working capital purposes.

 

The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (as defined below) (excluding the taxes payable on the interest earned on the Trust Account) at the time of signing a definitive agreement in connection with the initial Business Combination. However, the Company will complete the initial Business Combination only if the post-Business Combination company in which its public shareholders own shares will own or acquire 50% or more of the outstanding voting securities of the target or is otherwise not required to register as an investment company under the Investment Company Act (the “Investment Company Act”). There is no assurance that the Company will be able to complete a Business Combination successfully.

 

5

 

 

Upon the closing of the Public Offering, management deposited $351,900,000, or $10.20 per Unit sold in the Public Offering, including the proceeds of the Private Placement Warrants, in a trust account (“Trust Account”) and were only invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. However, on May 18, 2023, to mitigate the risk of being deemed to have been operating as an unregistered investment company under the Investment Company Act, the Company instructed Continental Stock Transfer & Trust Company, the trustee with respect to the Trust Account, to liquidate the U.S. government securities or money market funds held in the Trust Account and thereafter to hold all funds in the Trust Account in cash in an interest-bearing bank deposit account until the earlier of (i) the completion of a Business Combination or (ii) the distribution of the Trust Account. Interest on bank deposit accounts is variable and such accounts currently yield interest of approximately 4.65 % per annum. If the Company is unable to achieve more than minimal interest on the funds held in the Trust Account, the dollar amount the public shareholders would otherwise receive upon any redemption or liquidation of the Company would be less than if the assets in the Trust Account had remained in U.S. government securities or money market funds. Pursuant to the Trust Agreement, the trustee is not permitted to invest in other securities or assets.

 

Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, the proceeds from the Public Offering and the sale of the Private Placement Warrants will not be released from the Trust Account until the earliest of (i) the completion of the initial Business Combination, (ii) the redemption of the public shares if the Company is unable to complete the initial Business Combination within the Combination Period, subject to applicable law, and (iii) the redemption of the public shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association (the “Articles”) to modify the substance or timing of the Company’s obligation to redeem 100% of the public shares if the Company has not consummated an initial Business Combination within the Combination Period or with respect to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of its public shareholders.

 

The Company will provide its public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) without a shareholder vote by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed Business Combination or conduct a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require the Company to seek shareholder approval under applicable law or stock exchange listing requirement.

 

The Company will provide its public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account (which interest shall be net of taxes payable), divided by the number of then outstanding public shares, subject to the limitations and on the conditions described herein. The amount initially deposited into the Trust Account upon the consummation of the Public Offering was $351,900,000, representing $10.20 per public share. The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the marketing fee the Company will pay to the underwriters. There will be no redemption rights upon the completion of the initial Business Combination with respect to the Company’s warrants.

 

6

 

 

All of the public shares contain a redemption feature which allows for the redemption of such public shares in connection with the Company’s liquidation if there is a shareholder vote or tender offer in connection with the Company’s Business Combination and in connection with certain amendments to the Articles. In accordance with Accounting Standards Codification (“ASC”) 480-10-S99, redemption provisions not solely within the control of a company require Class A ordinary shares subject to redemption to be classified outside of permanent equity. Given that the public shares will be issued with other freestanding instruments (i.e., Public Warrants), the initial carrying value of Class A ordinary shares classified as temporary equity will be the allocated proceeds determined in accordance with ASC 470-20. The Class A ordinary shares are subject to ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. While redemptions cannot cause the Company’s net tangible assets to fall below $5,000,001, the public shares are redeemable and are classified as such on the condensed balance sheets until such date that a redemption event takes place.

 

Redemptions of the Company’s public shares may be subject to the satisfaction of conditions, including minimum cash conditions, pursuant to an agreement relating to the Company’s Business Combination. If the Company seeks shareholder approval of the Business Combination, the Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination, or such other vote as required by law or stock exchange rule. If a shareholder vote is not required by applicable law or stock exchange listing requirements, and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Articles, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (the “SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares and any public shares purchased during or after the IPO in favor of approving a Business Combination. Additionally, each public shareholder may elect to redeem their public shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction.

 

The ordinary shares subject to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the Public Offering, in accordance with Financial Accounting Standards Board (“FASB”) ASC Topic 480, “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company’s Class A ordinary shares are not classified as a “penny stock” upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination.

 

The Company will have until November 17, 2023 (or up to 30 months from the closing of the Public Offering if the Company extends the period of time to consummate a Business Combination by depositing into the Trust Account, for each one-month extension, the lesser of $0.03 per outstanding share and $250,000) to consummate the initial Business Combination. If the Company is unable to complete the initial Business Combination by the date by which it has to complete a Business Combination (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and its board of directors, liquidate and dissolve, subject, in each case, to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete the initial Business Combination within the Combination Period.

 

7

 

 

On June 12, 2023, the Company held an extraordinary general meeting of shareholders and the Company’s shareholders approved the following proposals: (1) a proposal to approve by special resolution an amendment of the Articles to give the Company the right to extend the Combination Period up to twelve (12) times for an additional one (1) month each time, from June 17, 2023 to June 17, 2024, by depositing into the Trust Account the lesser of (i) $0.03 per outstanding share and (ii) $250,000 (the “Extension Payment”), until the earlier of (a) the completion of a Business Combination and (b) the announcement of the Company’s intention to wind up its operations and liquidate (the “Extension Amendment Proposal”), and (2) a proposal to approve an amendment to the Trust Agreement to (a) provide the Company the right to extend the Combination Period up to twelve (12) times for an additional one (1) month each time from June 17, 2023 to June 17, 2024 by depositing into the Trust Account, for each one-month extension, the Extension Payment and (b) provide that the company shall hold the trust assets solely in cash in an interest-bearing demand deposit account at a bank from and after the effectiveness of the Charter Amendment and the Trust Amendment (the “Trust Agreement Amendment Proposal”).

 

In connection with the shareholders’ vote at the extraordinary general meeting, holders of 23,063,075 Class A ordinary shares of the Company exercised their right to redeem such shares (the “Redemption”) for a pro rata portion of the funds held in the Trust Account. As a result, approximately $243.2 million (approximately $10.55 per share) was removed from the Trust Account to pay such holders and approximately $120.9 million remained in the Trust Account. As a result of the Redemption, the Company had 20,061,925 ordinary shares outstanding, which include 11,436,925 Class A ordinary shares and 8,625,000 Class B ordinary shares.

 

On June 14, 2023, an aggregate of $500,000 was deposited by the Sponsor into the Trust Account of the Company for the Company’s public shareholders, representing $0.024 per public share, which enabled the Company to extend the period of time it has to consummate its Business Combination by two months to August 17, 2023 (the “Extension”). The Extension constitutes the first two of up to twelve one-month extensions permitted under the Company’s governing documents and provides the Company with additional time to complete its Business Combination.

 

On each of August 15, 2023, September 15, 2023 and October 12, 2023, an aggregate of $250,000 was deposited by Pala into the Trust Account of the Company for the Company’s public shareholders, representing $0.024 per public share, which enabled the Company to extend the period of time it has to consummate its Business Combination by one month for each Extension to September 17, 2023, October 17, 2023 and November 17, 2023, respectively. The Extensions constitute the third, fourth and fifth of up to twelve one-month extensions permitted under the Company’s governing documents and provide the Company with additional time to complete its Business Combination.

 

The Company’s initial shareholders, officers and directors, Pala and Roth have entered into a letter agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to any Founder Shares and public shares they hold in connection with the completion of the initial Business Combination, (ii) waive their redemption rights with respect to any Founder Shares and public shares they hold in connection with a shareholder vote to approve an amendment to the Articles to modify the substance or timing of the Company’s obligation to redeem 100% of the public shares if the Company has not consummated an initial Business Combination within the Combination Period or with respect to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity and (iii) waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares they hold if the Company fails to complete the initial Business Combination within the Combination Period or any extended period of time that the Company may have to consummate an initial Business Combination as a result of an amendment to the Articles (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the prescribed time frame).

 

8

 

 

The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.20 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.20 per public share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations, and the Company believes that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations.

 

On February 23, 2023, the Company signed a non-binding letter of intent for a Business Combination with a company in the battery technology sector.

 

Liquidity and Capital Resources

 

As of September 30, 2023, the Company had $123,724 in cash and a working capital deficit of $3,636,082.

 

The Company’s liquidity needs up to the closing of the IPO on December 17, 2021 had been satisfied through a payment from the Sponsor of $25,000 (see Note 5) for the Founder Shares to cover certain offering costs and the loan under an unsecured promissory note from the Sponsor of $300,000 (see Note 5). The promissory note was fully repaid as of the closing of the IPO.

 

In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 5). As of September 30, 2023 and December 31, 2022, the Company had approximately $1,758,000 and $0 of borrowings under the Working Capital Loans, respectively.

 

In connection with the Company’s assessment of going concern considerations in accordance with FASB Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until November 17, 2023 to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. Additionally, the Company may not have sufficient liquidity to fund the working capital needs of the Company until one year from the issuance of these unaudited condensed financial statements. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution, raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after November 17, 2023. The Company intends to complete a Business Combination before the mandatory liquidation date.

 

Risks and Uncertainties

 

Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these unaudited condensed financial statements. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

9

 

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited condensed financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the accounting and disclosure rules and regulations of the SEC.

 

Accordingly, the unaudited condensed financial statements do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, the Company’s unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and nine months ended September 30, 2023, are not necessarily indicative of the results that may be expected through December 31, 2023 or any future periods.

 

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 as filed with the SEC on March 30, 2023, which contains the audited financial statements and notes thereto.

 

Emerging Growth Company

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

Further, Section 102 (b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Use of Estimates

 

The preparation of unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

 

10

 

 

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $123,724 and $299,149 in cash and no cash equivalents as of September 30, 2023 and December 31, 2022, respectively.

 

Cash and Investments Held in Trust Account

 

As of December 31, 2022, substantially all of the assets held in the Trust Account were invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations.

 

Since May 18, 2023, all of the assets held in the Trust Account have been held solely in cash in an interest-bearing demand deposit account at a bank. Interest on bank deposit accounts is variable and such accounts currently yield interest of approximately 4.65% per annum.

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.

 

Offering Costs associated with the Initial Public Offering

 

Offering costs consist of underwriting, legal, accounting and other expenses incurred through the condensed balance sheet date that are directly related to the IPO. The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs are allocated ratably with the redeemable and non-redeemable shares they are allocated to. Offering costs associated with warrant liabilities are expensed, and offering costs associated with the Class A ordinary shares are charged to temporary equity. The Company incurred offering costs amounting to $7,607,233, consisting of $6,900,000 of underwriting commissions and $707,233 of other offering costs. Of this amount, $321,236 was allocated to warrants and charged to expense and the remainder was charged to temporary equity.

 

Ordinary Shares Subject to Possible Redemption

 

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ deficit. The Company’s Class A ordinary shares sold in the IPO feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of September 30, 2023 and December 31, 2022, 11,436,925 and 34,500,000 Class A ordinary shares, respectively, subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets.

 

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Such changes are reflected in additional paid-in capital, or in the absence of additional capital, in accumulated deficit.

 

11

 

 

As of September 30, 2023 and December 31, 2022, the Class A ordinary shares reflected in the condensed balance sheets are reconciled in the following table:

 

       
Gross proceeds   $ 345,000,000  
Less:        
Proceeds allocated to Public Warrants     (13,631,224 )
Class A ordinary shares issuance cost     (7,285,997 )
Add:        
Accretion of carrying value of redemption value     32,892,828  
Class A ordinary shares subject to redemption, December 31, 2022     356,975,607  
Add:        
Accretion of carrying value to redemption value     3,787,699  
Class A ordinary shares subject to redemption, March 31, 2023 (unaudited)     360,763,306  
Less:        
Redemptions     (243,268,708 )
Add:        
Accretion of carrying value to redemption value     3,372,942  
Class A ordinary shares subject to redemption, June 30, 2023 (unaudited)     120,867,540  
Add:        
Accretion of carrying value to redemption value     2,721,087  
Class A ordinary shares subject to redemption, September 30, 2023 (unaudited)   $ 123,588,627  

 

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the condensed balance sheets, primarily due to its short-term nature.

 

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The Company’s financial instruments are classified as either Level 1, Level 2 or Level 3. These tiers include:

 

● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

 

● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

 

● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 

Derivative Financial Instruments

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. The Company’s derivative instruments are recorded at fair value on the condensed balance sheets with changes in the fair value reported in the unaudited condensed statements of operations. Derivative assets and liabilities are classified on the condensed balance sheets as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the condensed balance sheet date.

 

12

 

 

Warrant Liabilities

 

The Company accounts for the warrants issued in connection with the Public Offering in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company will classify each warrant as a liability at its fair value. This liability is subject to re-measurement at each condensed balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s unaudited condensed statements of operations.

 

Net Income per Ordinary Share

 

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” Net income per share is computed by dividing net income by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture by the Sponsor. As of September 30, 2023 and December 31, 2022, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income per Class B ordinary share is the same as basic income per Class B ordinary share for the periods presented.

 

                                                               
    For the Three Months Ended
September 30,		     For the Nine Months Ended
September 30,		  
    2023     2022     2023     2022  
    Class A     Class B     Class A     Class B     Class A     Class B     Class A     Class B  
Basic and diluted net income per share:                                                                
Numerator:                                                                
Allocation of net income   $ 452,692     $ 341,392     $ 2,988,623     $ 747,156     $ 3,421,737     $ 1,174,733     $ 13,489,771     $ 3,372,443  
Denominator                                                                
Weighted-average shares outstanding     11,436,925       8,625,000       34,500,000       8,625,000       25,122,706       8,625,000       34,500,000       8,625,000  
Basic and diluted net income per share   $ 0.04     $ 0.04     $ 0.09     $ 0.09     $ 0.14     $ 0.14     $ 0.39     $ 0.39  

 

Income Taxes

 

The Company complies with the accounting and reporting requirements of FASB ASC 740, “Income Taxes,” which prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position.

 

The Company is considered an exempted Cayman Islands company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

 

Recent Accounting Pronouncements

 

Management does not believe that recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

 

13

 

 

NOTE 3 – INITIAL PUBLIC OFFERING

 

Public Units

 

On December 17, 2021, the Company consummated its IPO of 34,500,000 Units at a purchase price of $10.00 per Unit, which included the exercise of the underwriters’ full over-allotment option. Each Unit consists of one Class A ordinary share and one-half of one Public Warrant.

 

Public Warrants

 

Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as discussed herein. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Company’s initial shareholders or their affiliates, without taking into account any Founder Shares held by the Company’s initial shareholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”) (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A ordinary shares during the 20 trading day period starting on the trading day after the day on which the Company consummate the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below under “Redemption of warrants for cash” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.

 

The warrants will become exercisable 30 days after the completion of the Company’s initial Business Combination and will expire five years after the completion of the Company’s initial Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.

 

Redemption of warrants

 

Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):

 

  ● in whole and not in part;

 

  ● at a price of $0.01 per warrant;

 

  ● upon a minimum of 30 days’ prior written notice of redemption, which the Company refers to as the 30-day redemption period; and

 

  ● if, and only if, the closing price of the Company’s Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like and for certain issuances of Class A ordinary shares and equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination as described elsewhere in this prospectus) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.

 

14

 

 

NOTE 4 – PRIVATE PLACEMENT WARRANTS

 

Simultaneously with the consummation of the IPO, the Company consummated the Private Placement of 16,300,000 Private Placement Warrants and 3,051,111 Class B ordinary shares, par value $0.0001 per share, of the Company to the Sponsor, Pala, Cantor and Roth, generating gross proceeds to the Company of $16,300,000. In the Private Placement, the Sponsor purchased an aggregate of 9,445,000 Private Placement Warrants, Pala purchased an aggregate of 3,095,000 Private Placement Warrants and 2,751,111 Founder Shares, Cantor purchased an aggregate of 2,760,000 Private Placement Warrants and Roth purchased an aggregate of 1,000,000 Private Placement Warrants and 300,000 Founder Shares.

 

If the Private Placement Warrants are held by holders other than their initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the warrants included in the units being sold in the Public Offering.

 

NOTE 5 – RELATED PARTY TRANSACTIONS

 

Founder Shares

 

On August 4, 2021, the Sponsor paid $25,000, or approximately $0.003 per share, to cover certain offering costs in consideration for 7,187,500 Founder Shares, par value $0.0001.

 

On November 21, 2021, the Sponsor surrendered 2,966,667 Founder Shares for cancellation for nominal consideration. Roth committed to purchase 300,000 Founder Shares and 1,000,000 Private Placement Warrants in a private placement that closed simultaneously with the closing of the Public Offering. Additionally, Pala purchased 2,751,111 shares and 3,095,000 Private Placement Warrants in a private placement that closed simultaneously with the closing of the Public Offering.

 

On December 14, 2021, the Company issued 1,353,056 Founder Shares by way of a share capitalization which resulted in an aggregate of 8,540,556 Founder Shares outstanding. This total is comprised of 5,573,889 Founder Shares owned by the Sponsor, 2,666,667 owned by Pala and 300,000 owned by Roth. All shares and related amounts have been retroactively restated.

 

On December 16, 2021, the Company and Pala entered into a securities purchase agreement, pursuant to which the Company agreed to issue and sell 84,444 Founder Shares and 95,000 Private Placement Warrants to Pala for an aggregate purchase price of $190,000. This resulted in outstanding Founder Shares of 8,625,000 (5,573,889 owned by the Sponsor, 2,751,111 owned by Pala and 300,000 owned by Roth), of which 1,625,000 were subject to forfeiture to the extent the underwriters did not exercise their over-allotment option. On December 17, 2021, the underwriters fully exercised this option leaving no Founder Shares subject to forfeiture.

 

On October 23, 2023, October 30, 2023 and November 6, 2023, the Company and the Sponsor entered into non-redemption agreements (the “Non-Redemption Agreements”) with unaffiliated third parties (collectively, the “Investors”) in exchange for such Investors agreeing (i) to not redeem an aggregate of 5,000,500 Class A ordinary shares of the Company sold in its IPO (the “Non-Redeemed Shares”) in connection with the Meeting (as defined below) and (ii) to vote in favor of the Proposals (as defined below) at the Meeting (other than with respect to certain shares acquired or to be acquired pursuant to the Non-Redemption Agreements). In exchange for the foregoing commitment to not redeem such shares, the Sponsor has agreed to transfer to the Investors up to an aggregate of 1,000,100 Founder Shares held by the Sponsor contemporaneously with the closing of the Company’s Business Combination, provided that the Investors do not exercise their redemption rights with respect to the Non-Redeemed Shares in connection with the Meeting and the Proposals (as defined below) are approved.

 

15

 

 

The Company’s initial shareholders have agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of (A) one year after the completion of the initial Business Combination and (B) the date on which the Company complete a liquidation, merger, capital stock exchange or other similar transaction after the initial Business Combination that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property; except to certain permitted transferees and under certain circumstances as described in the prospectus relating to the Public Offering. Any permitted transferees will be subject to the same restrictions and other agreements of the Company’s initial shareholders with respect to any Founder Shares. The Company refers to such transfer restrictions as the lock-up. Notwithstanding the foregoing, the Founder Shares will be released from the lockup if (1) the closing price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination or (2) if the Company consummates a transaction after the initial Business Combination which results in its shareholders having the right to exchange their shares for cash, securities or other property.

 

Promissory Note – Related Party

 

On August 3, 2021, the Sponsor agreed to loan the Company up to $300,000 to be used for a portion of the expenses of the Public Offering. These loans are non-interest bearing, unsecured and are due at the earlier of March 31, 2022 or the closing of the Public Offering. The loan was repaid upon the closing of the Public Offering out of the offering proceeds not held in the Trust Account. As of September 30, 2023 and December 31, 2022, the Company had no borrowings under the promissory note and the promissory note is no longer available to the Company.

 

On April 5, 2023, the Company issued an unsecured convertible promissory note in the aggregate principal amount of $1,000,000 (the “Pala Note”) to Pala with each advance not to exceed $500,000. The Pala Note originally bore interest at a rate of ten percent (10.00%) per annum payable upon the earlier of June 16, 2023 (as may be extended in accordance with the terms of the Pala Note) and the effective date of the Company’s Business Combination. In the event that the Company does not consummate a Business Combination, the Pala Note will be repaid only from amounts remaining outside of the Company’s Trust Account. As of September 30, 2023, the Company had approximately $508,000 outstanding under the Pala Note. For the three and nine months ended September 30, 2023, the Company had approximately $15,000 and $27,000, respectively, in interest expense on the Pala Working Capital Note. The Pala Note has a conversion feature that is considered an embedded derivative, but the value is de minimis. As such, the Pala Note is presented at fair value on the accompanying condensed balance sheets. On August 8, 2023, the Company and Pala amended and restated the Pala Note (the “A&R Pala Note”) to (i) distinguish between loans made for the purposes of funding (x) the Company’s working capital requirements (the “Pala Working Capital Loans”) and (y) the Company’s Trust Account to extend the Company’s deadline to complete its business combination (the “Pala Trust Extension Loans”), (ii) permit interest to accrue at a rate equal to twenty percent (20.00%) per annum, compounded annually, on any and all then-outstanding Pala Working Capital Loans, (iii) clarify that no interest shall accrue on the Pala Trust Extension Loans and (iv) clarify that up to $6,900,000 of Pala Trust Extension Loans may be converted into Warrants, subject to availability.

 

On June 14, 2023, the Sponsor loaned the Extension Payment to the Company in order to support the Extension (the “Extension Loan”) and caused the Extension Payment to be deposited in the Company’s Trust Account for its public shareholders. In connection with the Extension Payment, the Company issued an unsecured promissory note in the aggregate principal amount of $2,000,000 (the “Sponsor Note”) to the Sponsor. The Sponsor Note originally bore interest at a rate of ten percent (10.0%) per annum. The Sponsor Note will be due and payable (subject to the waiver against trust provisions) on the earlier of (i) the date on which the Business Combination is consummated and (ii) the date of the Company’s liquidation. As of September 30, 2023, the Company had approximately $1,250,000 outstanding under the Sponsor Note.

 

16

 

 

On July 31, 2023, the Company and the Sponsor amended and restated the Sponsor Note (the “A&R Sponsor Note”) to (i) increase the aggregate principal amount available to be borrowed to up to $5,000,000, (ii) distinguish between loans made for the purposes of funding (x) the Company’s working capital requirements (the “Sponsor Working Capital Loans”) and (y) the Company’s Trust Account to extend the Company’s deadline to complete its Business Combination (the “Sponsor Trust Extension Loans”), and (iii) clarify that up to $1,500,000 of Sponsor Working Capital Loans and up to $6,900,000 of Sponsor Trust Extension Loans may be converted into Warrants, subject to availability (see Note 10).

 

On August 8, 2023, the Company and the Sponsor amended and restated the A&R Sponsor Note (the “Second A&R Sponsor Note”) to (i) permit interest to accrue at a rate equal to twenty percent (20.00%) per annum, compounded annually, on any and all then-outstanding Sponsor Working Capital Loans and (ii) clarify that no interest shall accrue on the Sponsor Trust Extension Loans (see Note 10).

 

On each of August 15, 2023, September 15, 2023 and October 12, 2023, an aggregate of $250,000 was deposited by Pala into the Trust Account of the Company for the Company’s public shareholders, representing $0.024 per public share, which enabled the Company to extend the period of time it has to consummate its Business Combination by one month for each Extension to September 17, 2023, October 17, 2023 and November 17, 2023, respectively. The Extensions constitute the third, fourth and fifth of up to twelve one-month extensions permitted under the Company’s governing documents and provide the Company with additional time to complete its Business Combination.

 

On October 12, 2023, the Company and Pala amended and restated the A&R Pala Note (the “Second A&R Pala Note”) to increase the aggregate principal amount available to be borrowed by up to $250,000 (see Note 10).

 

Working Capital Loans

 

In order to finance transaction costs in connection with an intended Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes the initial Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant at the option of the lender. The warrants would be identical to the Private Placement Warrants. As of September 30, 2023 and December 31, 2022, the Company had approximately $1,785,000 and $0 of borrowings under the Working Capital Loans, respectively.

 

Office Space, Secretarial and Administrative Services

 

Commencing on the date that the Company’s securities are first listed on the NYSE through the earlier of consummation of the initial Business Combination and the liquidation, the Company has agreed to pay the Sponsor a total of up to $15,000 per month for office space, secretarial and administrative support and to reimburse the Sponsor for any out-of-pocket expenses related to identifying, investigating and completing an initial Business Combination. For the three and nine months ended September 30, 2023, the Company did not incur fees for these services. For the three and nine months ended September 30, 2022, the Company incurred $0 and $45,000, respectively, in fees for these services. As of September 30, 2023 and December 31, 2022, the Company accrued $0 and $11,820, respectively, for the administrative support services in due to related party.

 

Service Provider Agreements

 

From time to time, the Company has entered into and may enter into agreements with various service providers and advisors, including investment banks, to help the Company identify targets, negotiate terms of potential Business Combinations, consummate a Business Combination and/or provide other services. In connection with these agreements, the Company may be required to pay such service providers and advisors fees in connection with their services to the extent that certain conditions, including the closing of a potential Business Combination, are met. If a Business Combination does not occur, the Company would not expect to be required to pay these contingent fees. There can be no assurance that the Company will complete a Business Combination.

 

17

 

 

NOTE 6 – COMMITMENTS AND CONTINGENCIES

 

Registration Rights

 

The holders of the (i) Founder Shares, (ii) Private Placement Warrants and the Class A ordinary shares underlying such Private Placement Warrants and (iii) Private Placement Warrants that may be issued upon conversion of Working Capital Loans will have registration rights to require the Company to register a sale of any of the Company’s securities held by them pursuant to a registration rights agreement signed in connection with the Public Offering. Pursuant to the registration rights agreement, the underwriters’ exercise of their over-allotment option in full and $1,500,000 of Working Capital Loans (which amount includes the committed sponsor loans) are converted into Private Placement Warrants, the Company will be obligated to register up to 26,425,000 Class A ordinary shares and 17,800,000 warrants. The number of Class A ordinary shares includes (i) 8,625,000 Class A ordinary shares to be issued upon conversion of the Founder Shares, (ii) 16,300,000 Class A ordinary shares to be issued upon exercise of the Private Placement Warrants and (iii) 1,500,000 Class A ordinary shares underlying the Private Placement Warrants issued upon conversion of Working Capital Loans. The number of warrants includes 16,300,000 Private Placement Warrants and 1,500,000 Private Placement Warrants issued upon conversion of Working Capital Loans. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggyback” registration rights with respect to registration statements filed subsequent to the Company’s completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriting Agreement

 

The underwriters earned a cash underwriting discount of two percent (2%) of the gross proceeds of the Public Offering (including the over-allotment), or $6,900,000.

 

The Company granted the underwriters a 45-day option from the date of the Public Offering to purchase up to an additional 4,500,000 units to cover over-allotments, if any. The underwriters exercised their full over-allotment option on December 17, 2021.

 

Business Combination Marketing Agreement

 

The Company engaged Cantor and Roth as advisors in connection with the Business Combination to assist in holding meetings with the shareholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing securities in connection with the Business Combination, assist in obtaining shareholder approval for the Business Combination and assist with press releases and public filings in connection with the Business Combination. The Company will pay Cantor and Roth a cash fee for such services upon the consummation of the Business Combination in an amount equal to 5.0% of the gross proceeds of the Public Offering (exclusive of any applicable finders’ fees which might become payable), which will only be paid upon the completion of the Company’s Business Combination. As of September 30, 2023 and December 31, 2022, neither Cantor nor Roth has provided any services under this agreement.

 

NOTE 7 – WARRANT LIABILITIES

 

The Company accounts for the 33,550,000 warrants issued in connection with the Public Offering (17,250,000 Public Warrants and 16,300,000 Private Placement Warrants) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company classifies each warrant as a liability at its fair value. This liability is subject to remeasurement at each condensed balance sheet date. With each such remeasurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s unaudited condensed statements of operations.

 

18

 

 

NOTE 8 – RECURRING FAIR VALUE MEASUREMENTS

 

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. U.S. GAAP (as defined in Note 2) establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of:

 

● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

 

● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

 

● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 

At September 30, 2023, assets held in the Trust Account were comprised of $123,589,515 in an interest-bearing demand deposit account at a bank. Through September 30, 2023, the Company withdrew $243,268,708 from the Trust Account in connection with the Redemption.

 

At December 31, 2022, assets held in the Trust Account were comprised of $356,976,495 in money market funds which are invested primarily in U.S. Treasury securities. Through December 31, 2022, the Company did not withdraw any interest income from the Trust Account.

 

The following tables present fair value information as of September 30, 2023 and December 31, 2022, of the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis and indicate the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value:

 

                       
September 30, 2023 (unaudited)   Level 1     Level 2     Level 3  
Liabilities:                        
Public Warrants   $ 1,897,500     $ -     $ -  
Private Warrants     -       -       1,908,768  
Total Liabilities   $ 1,897,500     $ -     $ 1,908,768  

 

December 31, 2022   Level 1     Level 2     Level 3  
Assets                        
Investments held in Trust Account   $ 356,976,495     $ -     $ -  
Total Assets   $ 356,976,495     $ -     $ -  
                         
Liabilities                        
Public Warrants   $ 1,093,650     $ -     $ -  
Private Warrants     -       -       1,125,515  
Total Liabilities   $ 1,093,650     $ -     $ 1,125,515  

 

19

 

 

At September 30, 2023 and December 31, 2022, the Company used a Monte Carlo model to value the private warrants. The estimated fair value of the public and private warrant liability is determined using Level 3 inputs. If factors or assumptions change, the estimated fair values could be materially different. Inherent in a binomial options pricing model are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield.

 

The following table provides quantitative information regarding Level 3 fair value measurements:

 

               
    September 30,
2023		     December 31,
2022		  
    (unaudited)        
Share price   $ 10.88     $ 10.27  
Strike price   $ 11.50     $ 11.50  
Term (in years)     0.89       5.41  
Volatility     3.5 %     7.8 %
Risk-free rate     5.48 %     4.74 %
Dividend yield     0       0  

 

The following table presents the changes in the fair value of Level 3 warrant liabilities:

 

                       
    Private
Placement		     Public     Warrant
Liabilities		  
Fair value as of December 31, 2022   $ 1,125,515     $ -     $ 1,125,515  
Change in fair value     558,888       -       558,888  
Fair value as of March 31, 2023 (unaudited)     1,684,403       -       1,684,403  
Change in fair value     (98,703 )     -       (98,703 )
Fair value as of June 30, 2023 (unaudited)     1,585,700       -       1,585,700  
Change in fair value     323,068       -       323,068  
Fair value as of September 30, 2023 (unaudited)   $ 1,908,768     $ -     $ 1,908,768  

 

Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. There were no transfers to/from Levels 1, 2, and 3 during the three and nine months ended September 30, 2023.

 

20

 

 

NOTE 9 – SHAREHOLDERS’ DEFICIT

 

Preference shares – The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 and with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September 30, 2023 and December 31, 2022, there were no preference shares issued or outstanding.

 

Class A ordinary shares – The Company is authorized to issue 200,000,000 Class A ordinary shares with a par value of $0.0001 per share. As of September 30, 2023 and December 31, 2022, there were 11,436,925 and 34,500,000 Class A ordinary shares, respectively, issued or outstanding, of which 11,436,925 and 34,500,000 Class A ordinary shares, respectively, were subject to possible redemption.

 

Class B ordinary shares – The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders are entitled to one vote for each share of Class B ordinary shares. As of September 30, 2023 and December 31, 2022, there were 8,625,000 Class B ordinary shares issued and outstanding. Of the 8,625,000 Class B ordinary shares, an aggregate of up to 1,625,000 shares were subject to forfeiture to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the initial shareholders will collectively own 20% of the Company’s issued and outstanding ordinary shares after the Public Offering. On December 17, 2021, the underwriters exercised their full over-allotment option, meaning no Founder Shares were subject to forfeiture on September 30, 2023 and December 31, 2022.

 

Holders of record of the Company’s Class A ordinary shares and Class B ordinary shares are entitled to one vote for each share held on all matters to be voted on by shareholders. Unless specified in the Articles or as required by the Companies Act or stock exchange rules, an ordinary resolution under Cayman Islands law, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the Company, is generally required to approve any matter voted on by the Company’s shareholders. Approval of certain actions require a special resolution under Cayman Islands law, which requires the affirmative vote of a majority of at least two-thirds of the shareholders who attend and vote at a general meeting of the company, and pursuant to the Articles, such actions include amending the Articles and approving a statutory merger or consolidation with another company. There is no cumulative voting with respect to the appointment of directors, meaning, following the Business Combination, the holders of more than 50% of the Company’s ordinary shares voted for the appointment of directors will be able to appoint all of the directors. Only holders of Class B ordinary shares will have the right to vote on the appointment of directors prior to the completion of the Business Combination. Holders of the public shares will not be entitled to vote on the appointment of directors during such time. These provisions of the Articles relating to the rights of holders of Class B ordinary shares to appoint directors may be amended if approved by holders of at least 90% of the Company’s ordinary shares voting in a general meeting. With respect to any other matter submitted to a vote of the Company’s shareholders, including any vote in connection with the Business Combination, except as required by law, holders of the Founder Shares and holders of the public shares will vote together as a single class, with each share entitling the holder to one vote. If the Company seek shareholder approval of the Business Combination, the Company will complete the Business Combination only if the Company obtain approval by way of an ordinary resolution under Cayman Islands law, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the company. In such case, the initial shareholders, officers and directors have agreed to vote their Founder Shares and any public shares purchased during or after the Public Offering (including in open-market and privately negotiated transactions) in favor of the Business Combination.

 

The Founder Shares will automatically convert into Class A ordinary shares concurrently with or immediately following the consummation of the Business Combination on a one-for-one basis, subject to adjustment for share subdivisions, share capitalizations, share dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A ordinary shares or equity-linked securities are issued or deemed issued in connection with the Business Combination, the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the total number of Class A ordinary shares outstanding after such conversion (after giving effect to any redemptions of Class A ordinary shares by public shareholders), including the total number of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the Business Combination, excluding any Class A ordinary shares or equity-linked securities or rights exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in the Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis.

 

21

 

 

NOTE 10 – SUBSEQUENT EVENTS

 

The Company evaluated subsequent events and transactions that occurred after the condensed balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, other than as noted below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

 

On October 12, 2023, the Company and Pala amended and restated the A&R Pala Note to increase the aggregate principal amount available to be borrowed by up to $250,000.

 

On October 12, 2023, an aggregate of $250,000 was deposited by Pala into the Trust Account of the Company for the Company’s public shareholders, representing $0.024 per public share, which enabled the Company to extend the period of time it has to consummate its Business Combination by one month to November 17, 2023. The Extension constitutes the fifth of up to twelve one-month extensions permitted under the Company’s governing documents and provides the Company with additional time to complete its Business Combination.

 

On October 24, 2023, the Company filed a definitive proxy statement regarding the extraordinary general meeting of shareholders to be held on November 14, 2023 (the “Meeting”). The purpose of the Meeting is to consider and vote upon proposals to (A) amend the Articles to remove the monthly Extension Payment the Company must make to extend the Combination Period and allow for an extension of the Combination Period until June 17, 2024 (the “Extended Date”) without depositing extra funds in the Trust Account (the “Extension Payment Removal Proposal”), (B) amend the Articles to eliminate (i) the limitation that the Company may not redeem public shares in an amount that would cause the Company’s net tangible assets to be less than $5,000,001 and (ii) the limitation that the Company shall not consummate an initial business combination unless the Company has net tangible assets of at least $5,000,001 immediately prior to, or upon consummation of, or any greater net tangible asset or cash requirement that may be contained in the agreement relating to, such initial business combination (the “Redemption Limitation Amendment Proposal”), (C) amend the Company’s investment management trust agreement, dated as of December 14, 2021 (as amended, the “Trust Agreement”), by and between the Company and Continental Stock Transfer & Trust Company, to allow the Company to extend the Combination Period until the Extended Date without depositing additional funds in the Trust Account (the “Second Trust Agreement Amendment Proposal”) and (D) adjourn the extraordinary general meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the extraordinary general meeting, there are not sufficient votes to approve the Extension Payment Removal Proposal, the Redemption Limitation Amendment Proposal or the Trust Agreement Amendment Proposal or where the board of directors of the Company has determined it is otherwise necessary or desirable (the “Adjournment Proposal”, and together with the Extension Payment Removal Proposal, the Redemption Limitation Amendment Proposal and the Second Trust Agreement Amendment Proposal, the “Proposals”). The foregoing summary of the Proposals does not purport to be complete and is qualified in its entirety by reference to the Company’s definitive proxy statement, filed with the SEC on October 24, 2023.

 

On October 23, 2023, October 30, 2023 and November 6, 2023, the Company and the Sponsor entered into Non-Redemption Agreements with the Investors in exchange for such Investors agreeing (i) to not redeem an aggregate of 5,000,500 Non-Redeemed Shares in connection with the Meeting and (ii) to vote in favor of the Proposals at the Meeting (other than with respect to certain shares acquired or to be acquired pursuant to the Non-Redemption Agreement). In exchange for the foregoing commitment to not redeem such shares, the Sponsor has agreed to transfer to the Investors up to an aggregate of 1,000,100 Founder Shares held by the Sponsor contemporaneously with the closing of the Company’s Business Combination, provided that the Investors do not exercise their redemption rights with respect to the Non-Redeemed Shares in connection with the Meeting and the Proposals are approved.

 

The foregoing summary of the Non-Redemption Agreements does not purport to be complete and is qualified in its entirety by reference to the form of Non-Redemption Agreement filed as Exhibit 10.1 the Company’s Current Report on Form 8-K filed with the SEC on October 23, 2023.

 

22

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

References to “we”, “us”, “our” or the “Company” are to Battery Future Acquisition Corp., except where the context requires otherwise. The following discussion should be read in conjunction with our unaudited condensed financial statements and related notes thereto included elsewhere in this report.

 

Cautionary Note Regarding Forward-Looking Statements

 

This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other Securities and Exchange Commission (“SEC”) filings.

 

Overview

 

We were incorporated as a Cayman Islands exempted company on July 29, 2021. We were incorporated for the purpose of effecting a merger, capital share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

 

On December 17, 2021, we consummated our initial public offering (the “IPO” or the “Public Offering”) of 34,500,000 units (including the underwriters’ full exercise of their over-allotment option) at $10.00 per unit (each, a “Unit”). Each Unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share.

 

The Company will have until November 17, 2023 (or up to 30 months from the closing of the Public Offering if we extend the period of time to consummate a Business Combination by depositing into the Trust Account, for each one-month extension, the lesser of $0.03 per outstanding share and $250,000) to consummate a Business Combination.

 

Pursuant to the terms of the Articles and the Trust Agreement, in order for the time available for us to consummate a Business Combination to be extended, the initial shareholders or their affiliates or designees, upon five days’ advance notice prior to the applicable deadline, must deposit into the Trust Account, pro rata in accordance with their percentage ownership of the total number of outstanding Founder Shares, the lesser of $0.03 per outstanding share and $250,000 for each one-month extension, on or prior to the date of the applicable deadline. Any such payments would be made in the form of an Extension Loan. If we complete a Business Combination, we will, at the option of our initial shareholders or their affiliates or designees, repay such loaned amounts out of the proceeds of the Trust Account released to us. If we do not complete a Business Combination, we will repay such loans only from funds held outside of the Trust Account. Our initial shareholders or their affiliates or designees are not obligated to fund the Trust Account to extend the time for us to complete a Business Combination. If we are unable to consummate a Business Combination within the applicable time period, we will, as promptly as reasonably possible but not more than five business days thereafter, redeem the public shares for a pro rata portion of the funds held in the Trust Account and as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject in each case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

 

23

 

 

If we are unable to complete a Business Combination by November 17, 2023 (or up to 30 months from the closing of the Public Offering if we extend the period of time to consummate a Business Combination by into the Trust Account, for each one-month extension, the lesser of $0.03 per outstanding share and $250,000) or during any extension period, we will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject, in each case, to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to our warrants, which will expire worthless if we fail to complete a Business Combination by November 17, 2023 (or up to 30 months from the closing of the Public Offering if we extend the period of time to consummate a Business Combination by depositing into the Trust Account, for each one-month extension, the lesser of $0.03 per outstanding share and $250,000).

 

Recent Developments

 

On May 22, 2023, we filed a definitive proxy statement regarding an extraordinary general meeting of shareholders to be held on June 12, 2023. The purpose of the extraordinary general meeting was to consider and vote upon proposals to (A) amend our amended and restated memorandum and articles of association to give us the right to extend the Combination Period up to twelve (12) times for an additional one (1) month each time, from June 17, 2023 to June 17, 2024, by depositing into the Trust Account the lesser of (i) $0.03 for each Class A ordinary share not redeemed in connection with the extraordinary general meeting, multiplied by the number of public shares then outstanding, and (ii) $250,000 (or pro rata portion thereof if less than a full month) (the “Extension Payment”), until the earlier of (a) the completion of a Business Combination and (b) the announcement of our intention to wind up its operations and liquidate (as extended, the “Extended Date”) (the “Extension Amendment Proposal”), (B) amend our investment management trust agreement, dated as of December 14, 2021, by and between us and Continental Stock Transfer & Trust Company, to (i) allow us to extend the Combination Period up to twelve (12) times for an additional one (1) month each time, from June 17, 2023, to the Extended Date by depositing into the Trust Account the Extension Payment until the Extended Date and (ii) provide that we shall hold the trust assets solely in cash from and after the effectiveness of the Extension Amendment Proposal and the Trust Agreement Amendment Proposal (the “Trust Agreement Amendment Proposal”) and (C) adjourn the extraordinary general meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the extraordinary general meeting, there are not sufficient votes to approve the Extension Amendment Proposal or the Trust Agreement Amendment Proposal or where the board of directors has determined it is otherwise necessary or desirable (the “Adjournment Proposal”). The foregoing summary of the Extension Amendment Proposal, Trust Agreement Amendment Proposal and the Adjournment Proposal does not purport to be complete and is qualified in its entirety by reference to the Company’s definitive proxy statement, filed with the SEC on May 22, 2023.

 

On June 12, 2023, we held an extraordinary general meeting of shareholders, and our shareholders approved the Extension Amendment Proposal and the Trust Agreement Amendment Proposal.

 

In connection with the shareholders’ vote at the extraordinary general meeting, holders of 23,063,075 Class A ordinary shares exercised their right to redeem such shares (the “Redemption”) for a pro rata portion of the funds held in the Trust Account. As a result, approximately $242.4 million (approximately $10.51 per share) was removed from the Trust Account to pay such holders and approximately $119.6 million remained in the Trust Account. As a result of the Redemption, we have 20,061,925 ordinary shares outstanding, which includes 11,436,925 Class A ordinary shares and 8,625,000 Class B ordinary shares.

 

24

 

 

On June 14, 2023, the Extension Payment was deposited by the Sponsor into the Trust Account for our public shareholders, representing $0.024 per public share, which enabled us to extend the period of time we have to consummate a Business Combination by two months to August 17, 2023 (the “Extension”). The Extension constitutes the first two of up to twelve one-month extensions permitted under our governing documents and provides us with additional time to complete a Business Combination.

 

On each of August 15, 2023 and September 15, 2023, an aggregate of $250,000 was deposited by Pala into the Trust Account for our public shareholders, representing $0.024 per public share, which enabled us to extend the period of time we have to consummate a Business Combination by one month for each Extension to September 17, 2023 and October 17, 2023, respectively. The Extensions constitute the third and fourth of up to twelve one-month extensions permitted under our governing documents and provide us with additional time to complete a Business Combination.

 

On October 12, 2023, the Company and Pala amended and restated the A&R Pala Note to increase the aggregate principal amount available to be borrowed by up to $250,000.

 

On October 12, 2023, an aggregate of $250,000 was deposited by Pala into the Trust Account for our public shareholders, representing $0.024 per public share, which enabled us to extend the period of time we have to consummate our Business Combination by one month to November 17, 2023. The Extension constitutes the fifth of up to twelve one-month extensions permitted under our governing documents and provides us with additional time to complete our Business Combination.

 

On October 24, 2023, we filed a definitive proxy statement regarding an extraordinary general meeting of shareholders to be held on November 14, 2023 (the “Meeting”). The purpose of the Meeting is to consider and vote upon proposals to (A) amend the Articles to remove the monthly Extension Payment we must make to extend the Combination Period and allow for an extension of the Combination Period until June 17, 2024 (the “Extended Date”) without depositing extra funds in the Trust Account (the “Extension Payment Removal Proposal”), (B) amend the Articles to eliminate (i) the limitation that we may not redeem public shares in an amount that would cause our net tangible assets to be less than $5,000,001 and (ii) the limitation that we shall not consummate an initial business combination unless we have net tangible assets of at least $5,000,001 immediately prior to, or upon consummation of, or any greater net tangible asset or cash requirement that may be contained in the agreement relating to, such initial business combination (the “Redemption Limitation Amendment Proposal”), (C) amend our investment management trust agreement, dated as of December 14, 2021 (as amended, the “Trust Agreement”), by and between us and Continental Stock Transfer & Trust Company, to allow us to extend the Combination Period until the Extended Date without depositing additional funds in the Trust Account (the “Second Trust Agreement Amendment Proposal”) and (D) adjourn the extraordinary general meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the extraordinary general meeting, there are not sufficient votes to approve the Extension Payment Removal Proposal, the Redemption Limitation Amendment Proposal or the Trust Agreement Amendment Proposal or where the board of directors has determined it is otherwise necessary or desirable (the “Adjournment Proposal”, and together with the Extension Payment Removal Proposal, the Redemption Limitation Amendment Proposal and the Second Trust Agreement Amendment Proposal, the “Proposals”). The foregoing summary of the Proposals does not purport to be complete and is qualified in its entirety by reference to our definitive proxy statement filed with the SEC on October 24, 2023.

 

On October 23, 2023, October 30, 2023 and November 6, 2023, the Company and the Sponsor entered into Non-Redemption Agreements with the Investors in exchange for such Investors agreeing (i) to not redeem an aggregate of 5,000,500 Non-Redeemed Shares in connection with the Meeting and (ii) to vote in favor of the Proposals at the Meeting (other than with respect to certain shares acquired or to be acquired pursuant to the Non-Redemption Agreement). In exchange for the foregoing commitment to not redeem such shares, the Sponsor has agreed to transfer to the Investors up to an aggregate of 1,000,100 Founder Shares held by the Sponsor contemporaneously with the closing of the Company’s Business Combination, provided that the Investors do not exercise their redemption rights with respect to the Non-Redeemed Shares in connection with the Meeting and the Proposals are approved.

 

25

 

 

Results of Operations

 

Our entire activity from July 29, 2021 (inception) through September 30, 2023, was in preparation for the Public Offering, and since the Public Offering, our search for a prospective Business Combination target. We will not generate any operating revenues until the closing and completion of our Business Combination, at the earliest. We expect to generate non-operating income in the form of interest income on marketable securities held after the Public Offering. We expect that we will incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with searching for, and completing, a Business Combination.

 

For the three months ended September 30, 2023, we had net income of $794,084 which consisted of interest earned on marketable securities held in the Trust Account of $2,221,087 and change in fair value of warrant liabilities of $683,593, offset by formation and operating costs of $728,366 and interest on the Pala Note (as defined below) and the Sponsor Note (as defined below) of $15,044.

 

For the three months ended September 30, 2022, we had net income of $3,735,779 which consisted of a favorable change in fair value of warrant liabilities of $2,382,595 and interest earned on marketable securities held in the Trust Account of $1,588,335, offset by formation and operating costs of $235,151.

 

For the nine months ended September 30, 2023, we had net income of $4,596,470 which consisted of interest earned on marketable securities held in the Trust Account of $8,881,728, offset by change in fair value of warrant liabilities of $1,587,103, formation and operating costs of $2,670,974 and interest on the Pala Note (as defined below) and the Sponsor Note (as defined below) of $27,181.

 

For the nine months ended September 30, 2022, we had net income of $16,862,214 which consisted of a favorable change in fair value of warrant liabilities of $16,142,727 and interest earned on marketable securities held in the Trust Account of $2,098,809, offset by formation and operating costs of $1,379,322.

 

Liquidity and Capital Resources

 

As of September 30, 2023, we had $123,724 in cash and a working capital deficit of $3,636,082.

 

The Company’s liquidity needs up to the closing of the IPO on December 17, 2021 had been satisfied through a payment from the Sponsor of $25,000 for the Founder Shares to cover certain offering costs and the loan under an unsecured promissory note from the Sponsor of $300,000. The promissory note was fully repaid as of the closing of the IPO.

 

In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans. As of September 30, 2023 and December 31, 2022, the Company had approximately $1,758,000 and $0 of borrowings under the Working Capital Loans, respectively.

 

On April 5, 2023, we issued an unsecured convertible promissory note in the aggregate principal amount of $1,000,000 (the “Pala Note”) to Pala Investments Limited (“Pala”) with each advance not to exceed $500,000. The Pala Note originally bore interest at a rate of ten percent (10.00%) per annum payable upon the earlier of June 16, 2023 (as may be extended in accordance with the terms of the Pala Note) and the effective date of the Company’s Business Combination. In the event that we do not consummate a Business Combination, the Pala Note will be repaid only from amounts remaining outside of our Trust Account. As of September 30, 2023, the Company had approximately $508,000 outstanding under the Pala Note. For the three and nine months ended September 30, 2023, the Company had approximately $10,000 and $180,000, respectively, in interest expense on the Pala Note. The Pala Note has a conversion feature that is considered an embedded derivative, but the value is de minimis. As such, the Pala Note is presented at fair value on the accompanying balance sheets. On August 8, 2023, the Company and Pala amended and restated the Pala Note (the “A&R Pala Note”) to (i) distinguish between loans made for the purposes of funding (x) the Company’s working capital requirements (the “Pala Working Capital Loans”) and (y) the Company’s trust account to extend the Company’s deadline to complete its business combination (the “Pala Trust Extension Loans”), (ii) permit interest to accrue at a rate equal to twenty percent (20.00%) per annum, compounded annually, on any and all then-outstanding Pala Working Capital Loans, (iii) clarify that no interest shall accrue on the Pala Trust Extension Loans and (iv) clarify that up to $6,900,000 of Pala Trust Extension Loans may be converted into Warrants, subject to availability.

 

26

 

 

On June 14, 2023, the Sponsor loaned the Extension Payment to the Company in order to support the Extension (the “Extension Loan”) and caused the Extension Payment to be deposited in the Company’s Trust Account for its public shareholders. In connection with the Extension Payment, the Company issued an unsecured promissory note in the aggregate principal amount of $2,000,000 (the “Sponsor Note”) to the Sponsor. The Sponsor Note originally bore interest at a rate of ten percent (10.0%) per annum. The Sponsor Note will be due and payable (subject to the waiver against trust provisions) on the earlier of (i) the date on which the Business Combination is consummated and (ii) the date of the Company’s liquidation. As of September 30, 2023, the Company had approximately $1,250,000 outstanding under the Sponsor Note. For the three and nine months ended September 30, 2023, the Company had approximately $5,000 and $9,000, respectively, in interest expense on the Sponsor Note.

 

On July 31, 2023, the Company and the Sponsor amended and restated the Sponsor Note (the “A&R Sponsor Note”) to (i) increase the aggregate principal amount available to be borrowed to up to $5,000,000, (ii) distinguish between loans made for the purposes of funding (x) the Sponsor Working Capital Loans and (y) the Sponsor Extension Loans, and (iii) clarify that up to $6,900,000 of Sponsor Working Capital Loans and up to $1,500,000 of Sponsor Trust Extension Loans may be converted into Warrants, subject to availability.

 

On August 8, 2023, the Company and the Sponsor amended and restated the A&R Sponsor Note (the “Second A&R Sponsor Note”) to (i) permit interest to accrue at a rate equal to twenty percent (20.00%) per annum, compounded annually, on any and all then-outstanding Sponsor Working Capital Loans and (ii) clarify that no interest shall accrue on the Sponsor Trust Extension Loans.

 

On each of August 15, 2023, September 15, 2023 and October 12, 2023, an aggregate of $250,000 was deposited by Pala into the Trust Account for our public shareholders, representing $0.024 per public share, which enabled us to extend the period of time we have to consummate our Business Combination by one month for each Extension to September 17, 2023, October 17, 2023 and November 17, 2023, respectively. The Extensions constitute the third, fourth and fifth of up to twelve one-month extensions permitted under our governing documents and provide us with additional time to complete our Business Combination.

 

On October 12, 2023, the Company and Pala amended and restated the A&R Pala Note (the “Second A&R Pala Note”) to increase the aggregate principal amount available to be borrowed by up to $250,000.

 

In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until November 17, 2023 to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. Additionally, the Company may not have sufficient liquidity to fund the working capital needs of the Company until one year from the issuance of these unaudited condensed financial statements. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution, raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after November 17, 2023.

 

Critical Accounting Policies

 

The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

 

27

 

 

Ordinary Shares Subject to Possible Redemption

 

The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value.

 

Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, 11,436,925 Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets.

 

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of Class A ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid-in capital and accumulated deficit.

 

Net Income Per Ordinary Share

 

The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Earnings and losses are shared pro rata between the two classes of shares. Calculation of diluted net income per share for the three and nine months ended September 30, 2023 does not consider the effect of the warrants underlying the Units sold in the Public Offering and the Private Placement Warrants to purchase an aggregate of 33,550,000 Class A ordinary shares subject to possible redemption in the calculation of diluted income per share because they are contingent on future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income per ordinary share is the same as basic net income per ordinary share for such periods.

 

Warrant Liabilities

 

We account for the warrants issued in connection with the Public Offering in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, we will classify each warrant as a liability at its fair value. This liability is subject to re-measurement at each condensed balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in our unaudited condensed statements of operations.

 

Recent Accounting Pronouncements

 

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on our unaudited condensed financial statements.

 

Off-Balance Sheet Arrangements

 

As of the date of this Quarterly Report on Form 10-Q, we did not have any off-balance sheet arrangements.

 

28

 

 

Commitments and Contractual Obligations

 

Registration Rights Agreement

 

Pursuant to the Registration Rights Agreement, dated December 14, 2021, by and among us, the Sponsor, Pala, Cantor, Roth and the other holders party thereto, the holders of the (i) Founder Shares, (ii) Private Placement Warrants and the Class A ordinary shares underlying such Private Placement Warrants, (iii) Private Placement Warrants that may be issued upon conversion of Working Capital Loans and (iv) Private Placement Warrants that may be issued upon conversion of the Extension Loans will have registration rights to require us to register a sale of any of our securities held by them. The holders of these securities are entitled to certain demand and “piggyback” registration rights. We will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriting Agreement

 

We granted the underwriters a 45-day option from the date of the IPO to purchase up to an additional 4,500,000 Units to cover over-allotments, if any. The underwriters exercised their over-allotment option in full on December 17, 2021.

 

On December 17, 2021, the underwriters earned a cash underwriting discount of two percent (2.0%) of the gross proceeds of the IPO, or $6,900,000. Additionally, the underwriters will be entitled to a marketing fee of five percent (5.0%) of the gross proceeds of the IPO, or $17,250,000, upon the completion of our Business Combination.

 

JOBS Act

 

On April 5, 2012, the JOBS Act was signed into law. The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” under the JOBS Act and are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We elected to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, our unaudited condensed financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

 

As an “emerging growth company,” we are not required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis), and (iv) disclose comparisons of the chief executive officer’s compensation to median employee compensation. These exemptions will apply for a period of five (5) years following the completion of the Public Offering or until we otherwise no longer qualify as an “emerging growth company.”

 

29

 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

We are a smaller reporting company as defined by Rule 12b-2 under the Exchange Act and are not required to provide the information otherwise required under this item.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this Quarterly Report, is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. Our management evaluated, with the participation of our chief executive officer and chief financial officer (our “Certifying Officers”), the effectiveness of our disclosure controls and procedures as of September 30, 2023, pursuant to Rule 13a-15 (b) under the Exchange Act. Based upon that evaluation, our Certifying Officers concluded that, as of the evaluation date, our disclosure controls and procedures were effective.

 

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

30

 

 

PART II-OTHER INFORMATION

 

Item 1. Legal Proceedings

 

None.

 

Item 1A. Risk Factors

 

There have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K filed with the SEC on March 30, 2023, as supplemented by our Quarterly Report on Form 10-Q filed with the SEC on May 15, 2023.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

Unregistered Sales of Equity Securities

 

Simultaneously with the closing of the IPO, the Company consummated the private placement of an aggregate of 16,300,000 warrants (the “Private Placement Warrants”) and 3,051,111 Class B ordinary shares, par value $0.0001 per share, of the Company (the “Founder Shares”) to Battery Future Sponsor LLC (the “Sponsor”), Pala Investment Limited (“Pala”), Cantor Fitzgerald & Co. (“Cantor”) and Roth Capital Partners, LLC (“Roth”), generating gross proceeds to the Company of $16,300,000 (the “Private Placement”). No underwriting discounts or commissions were paid with respect to such sale. The Private Placement was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. In the Private Placement, the Sponsor purchased an aggregate of 9,445,000 Private Placement Warrants, Pala purchased an aggregate of 3,095,000 Private Placement Warrants and 2,751,111 Founder Shares, Cantor purchased an aggregate of 2,760,000 Private Placement Warrants and Roth purchased an aggregate of 1,000,000 Private Placement Warrants and 300,000 Founder Shares.

 

The Private Placement Warrants are identical to the Warrants included as part of the Units sold in the IPO, except that the Private Placement Warrants (including the underlying securities) are subject to certain transfer restrictions and the holders thereof are entitled to certain registration rights, and, if held by the original holder or their permitted assigns, the underlying warrants (i) may be exercised on a cashless basis, (ii) are not subject to redemption and (iii) with respect to such warrants held by Cantor and Roth, will not be exercisable more than five years from the commencement of sales in the IPO. If the Private Placement Warrants are held by holders other than the Sponsor, Pala, Cantor or Roth or their respective permitted transferees, the Private Placement Warrants will be redeemable by the Company in all redemption scenarios and exercisable by holders on the same basis as the Public Warrants.

 

Use of Proceeds

 

On December 17, 2021, the Company consummated its IPO of 34,500,000 units, including the issuance of 4,500,000 Units as a result of the underwriters’ exercise of their over-allotment option in full. Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A Ordinary Shares”), and one-half of one redeemable warrant of the Company (each whole warrant, a “Warrant”), with each Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share, subject to adjustment. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $345,000,000.

 

After deducting the underwriting discounts and commissions and incurred offering costs, a total of $351,900,000, comprised of $335,600,000 of the net proceeds from the IPO and $16,300,000 of the proceeds of the Private Placement, was placed in a trust account at J.P. Morgan Chase Bank, N.A. maintained by Continental Stock Transfer & Trust Company, acting as trustee. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes and up to $100,000 of interest to pay dissolution expenses, the funds held in the Trust Account will not be released from the Trust Account until the earliest of (i) the completion of the Company’s Business Combination, (ii) the redemption of any of the Class A Ordinary Shares included in the Units sold in the IPO (the “public shares”) properly submitted in connection with a shareholder vote to amend the Articles (A) to modify the substance or timing of the Company’s obligation to redeem 100% of the public shares if it does not complete a Business Combination by November 17, 2023 (or up to 30 months, if applicable) from the closing of the IPO or (B) with respect to any other material provisions relating to shareholders’ rights or pre-Business Combination activity or (iii) the redemption of the Company’s public shares if it is unable to complete its Business Combination by November 17, 2023 (or up to 30 months from the closing of the IPO if the Company extends the period of time to consummate its Business Combination by up to an additional ten months, subject to the Sponsor, Pala and Roth depositing additional funds into the Trust Account as described in the Registration Statement), subject to applicable law.

 

31

 

 

Item 3. Defaults upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

None.

 

32

 

 

Item 6. Exhibits.

 

Exhibit

Number

   Description
31.1*   Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
31.2*   Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
32.1*   Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
32.2*   Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
101.INS   Inline XBRL Instance Document
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
     
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

 
* These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

 

33

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: November 13, 2023

 

By: /s/ Kristopher Salinger  
Name: Kristopher Salinger  
Title: Chief Financial Officer
(Principal Financial and Accounting Officer)		  

 

34